Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

1139188

registered interest
date	16/07/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Cannabis: Medical Treatments
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, how many UK companies have been issued with a licence to sell cannabis products for the NHS.
tabling member constituency	Ross, Skye and Lochaber
tabling member printed	Ian Blackford
uin	277762
answer	answer is ministerial correction date of answer 22/07/2019 answer text <p>Any company meeting the standards for the manufacture of unlicensed medicinal products, can supply cannabis-based products for medicinal use.</p><p>Cannabis-based products for medicinal use are Schedule 2 controlled drugs under the Misuse of Drugs Regulations 2001, which means that manufacturers, importers and distributors of these products must hold valid Home Office and Medicines and Healthcare products Regulatory Agency (MHRA) licences for the relevant activities which will include possession, supply and production of controlled drugs. Where products are sourced from abroad, importers must obtain an import licence from the Home Office and the MHRA each time they import these products.</p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 22/07/2019 15:41:10 answering member 4455 label Biography information for Seema Kennedy
tabling member	4390 label Biography information for Ian Blackford

1139193

registered interest
date	16/07/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	HIV Infection: Drugs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what discussions he is having with the Chancellor of the Exchequer on a long-term and sustainable funding package for the extension of PrEP trials.
tabling member constituency	Dulwich and West Norwood
tabling member printed	Helen Hayes
uin	277792
answer	answer is ministerial correction date of answer 22/07/2019 answer text <p>My Rt. hon. Friend the Secretary of State for Health and Social Care has had numerous discussions with cabinet ministers to discuss a range of topics in advance of the Spending Review. Public health funding for 2020 onwards, including for HIV and sexual health services, will be considered carefully in the next Spending Review, in the light of the available evidence.</p><p>It is for individual local authorities to decide their spending priorities based on an assessment of local need, including sexual health services, taking account of their statutory duties. Participation in the pre-exposure prophylaxis Impact Trial is on a voluntary basis.</p> answering member constituency South Ribble answering member printed Seema Kennedy grouped question UIN 277793 question first answered 22/07/2019 15:40:08 answering member 4455 label Biography information for Seema Kennedy
tabling member	4510 label Biography information for Helen Hayes

1139194

registered interest
date	16/07/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	HIV Infection: Drugs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what discussions he has had with the Chancellor of the Exchequer on a small investment for public health budgets to increase the provision for PrEP trials.
tabling member constituency	Dulwich and West Norwood
tabling member printed	Helen Hayes
uin	277793
answer	answer is ministerial correction date of answer 22/07/2019 answer text <p>My Rt. hon. Friend the Secretary of State for Health and Social Care has had numerous discussions with cabinet ministers to discuss a range of topics in advance of the Spending Review. Public health funding for 2020 onwards, including for HIV and sexual health services, will be considered carefully in the next Spending Review, in the light of the available evidence.</p><p>It is for individual local authorities to decide their spending priorities based on an assessment of local need, including sexual health services, taking account of their statutory duties. Participation in the pre-exposure prophylaxis Impact Trial is on a voluntary basis.</p> answering member constituency South Ribble answering member printed Seema Kennedy grouped question UIN 277792 question first answered 22/07/2019 15:40:08 answering member 4455 label Biography information for Seema Kennedy
tabling member	4510 label Biography information for Helen Hayes

1139199

registered interest
date	16/07/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	NHS: Pay
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, with reference to paragraph 170 of his Department's Annual Report 2018-19 on the increased NHS resource budget and to the Written Statement on NHS Workforce made on 21 March 2018, HCWS574, if he will clarify when the additional £4.2 billion was agreed by the Chancellor for the NHS Agenda for Change three year pay deal.
tabling member constituency	Leicester South
tabling member printed	Jonathan Ashworth
uin	277749
answer	answer is ministerial correction date of answer 22/07/2019 answer text <p>Funding for the multi-year (2018/19 – 2020/21) Agenda for Change (AfC) pay and contract reform deal was confirmed alongside the Government’s announcement via a Written Ministerial Statement (<a href="https://www.parliament.uk/business/publications/written-questions-answers-statements/written-statement/Commons/2018-06-27/HCWS803/" target="_blank">HCWS803</a>) laid before the House on 27 June 2018 that the Government was accepting the collectively agreed deal. This statement followed the previous Written Ministerial Statement (<a href="https://www.parliament.uk/business/publications/written-questions-answers-statements/written-statement/Commons/2018-03-21/HCWS574/" target="_blank">HCWS574</a>) laid before the house on 21 March 2018 in which additional funding for the AfC deal was committed to should trades union members agree to the deal.</p><p>In line with the Chancellor’s commitment at Budget 2017, the Government released the £800 million already set aside to support the first year of the deal for 2018/19 in England.</p><p>Funding for the remaining two years of the deal (2019/20 and 2020/21) has been made available as part of the long-term funding settlement for the National Health Service.</p><p> </p><p> </p><p><strong> </strong></p><p><strong> </strong></p> answering member constituency Wimbledon answering member printed Stephen Hammond question first answered 22/07/2019 15:33:16 answering member 1585 label Biography information for Stephen Hammond
tabling member	4244 label Biography information for Jonathan Ashworth

1139201

registered interest
date	16/07/2019
answering body	Ministry of Justice
answering dept id	54
answering dept short name	Justice
answering dept sort name	Justice
hansard heading	Ministry of Justice: Overtime
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Justice, how much his Department paid in overtime payments to (a) directly employed and (b) agency staff in each year since 2010.
tabling member constituency	Leeds East
tabling member printed	Richard Burgon
uin	277786
answer	answer is ministerial correction date of answer 22/07/2019 answer text <p>Responses to the two parts of the questions are as follows:</p><p>Part (a) - At this point it cannot be determined if the full data set for directly employed staff is available. The reason for this is because in Feb 2017 MOJ rationalised its payrolls and moved to a new payroll system (known as SOP), so any prior year’s data, if available, would need to be sourced from legacy systems. To do this would require raising requests with several legacy suppliers who could then determine if the data was available. The cost of doing this would be disproportionate. Only data for the following financial periods are available. This data covers the MOJ group:</p><p>- February 2017 - March 2017 - £18,418,976</p><p>- April 2017 – March 2018 - £103,919,954</p><p>- April 2018 – March 2019 - £93,402,051</p><p>- April 2019 - June 2019 - £21,944,613</p><p>The average number of employees throughout the above periods was:</p><p>- In 2017 - 71,000</p><p>- In 2018 – 72,000</p><p>- In 2019 – 76,000</p><p>It should also be noted that there are many reasons why someone may get paid overtime, for example, in prisons for carrying out bedwatch or dealing with incidents of unrest. All of these elements have been included in the above figures.</p><p> </p><p>Part (b) – This data is not available because MOJ engage agency staff via third party providers such as Brook Street, and these staff are not on the MOJ payroll and therefore details of any overtime paid are not held by MOJ. MOJ pay for these individuals, who are generally charged out at an hourly rate, via invoice.</p> answering member constituency Charnwood answering member printed Edward Argar question first answered 22/07/2019 16:01:33 answering member 4362 label Biography information for Edward Argar
tabling member	4493 label Biography information for Richard Burgon

1139207

registered interest
date	16/07/2019
answering body	Department for Work and Pensions
answering dept id	29
answering dept short name	Work and Pensions
answering dept sort name	Work and Pensions
hansard heading	Personal Independence Payment: Multiple Sclerosis
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Work and Pensions, how many people with multiple sclerosis in receipt of disability living allowance who (a) underwent a reassessment and (b) made a new application for personal independence payments had their (i) application rejected and (ii) award reduced as a result of an informal observation made by the assessor in each year since 2013.
tabling member constituency	East Lothian
tabling member printed	Martin Whitfield
uin	277818
answer	answer is ministerial correction date of answer 22/07/2019 answer text <p>The information requested is not readily available and to provide it would incur disproportionate cost.</p><p> </p><p>Informal observations form part of the suite of evidence used by Health Professionals at the face to face assessment to help Case Managers determine entitlement to benefit, along with medical evidence, history of conditions, social and occupational history, functional history including the ‘typical day’ and the functional examination.</p><p> </p><p>More information can be found at paragraph 1.6 in the Personal Independence Payment Assessment Guide at the following link:</p><p> </p><p><a href="https://www.gov.uk/government/publications/personal-independence-payment-assessment-guide-for-assessment-providers/pip-assessment-guide-part-1-the-assessment-process#carrying-out-pip-assessments" target="_blank">https://www.gov.uk/government/publications/personal-independence-payment-assessment-guide-for-assessment-providers/pip-assessment-guide-part-1-the-assessment-process#carrying-out-pip-assessments</a></p> answering member constituency North Swindon answering member printed Justin Tomlinson grouped question UIN 277271 question first answered 22/07/2019 16:16:40 answering member 4105 label Biography information for Justin Tomlinson
tabling member	4626 label Biography information for Martin Whitfield

1139214

registered interest
date	16/07/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Cancer: Health Services
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, if he will commission a fully-funded long-term cancer workforce plan for the NHS to help ensure increased patient demand is met.
tabling member constituency	Easington
tabling member printed	Grahame Morris
uin	277702
answer	answer is ministerial correction date of answer 22/07/2019 answer text <p>The interim NHS People Plan, published on 3 June 2019, puts the workforce at the heart of the National Health Service and will ensure we have the staff needed to deliver high quality care. A final People Plan will be published soon after the conclusion of the 2019 Spending Review.</p><p>Phase 1 of the Cancer Workforce Plan for England, published in December 2017 by Health Education England (HEE), set out plans to expand capacity and skills in the cancer workforce, including targeting additional training support for seven priority professions which are key to cancer prevention, diagnosis and treatment, such as clinical radiology, histopathology, oncology and diagnostic and therapeutic radiography.</p><p>HEE will now work with NHS England and NHS Improvement to understand the longer-term workforce implications of further development of cancer services. This work will inform the final People Plan.</p><p> </p><p><strong> </strong></p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 22/07/2019 14:31:02 answering member 4455 label Biography information for Seema Kennedy
tabling member	3973 label Biography information for Grahame Morris

1139217

registered interest
date	16/07/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Clinical Commissioning Groups: Finance
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps his Department is taking to ensure funding for Clinical Commissioning Groups is equitable and protects patient outcomes.
tabling member constituency	Peterborough
tabling member printed	Ms Lisa Forbes
uin	277858
answer	answer is ministerial correction date of answer 22/07/2019 answer text <p>The allocation of funding to clinical commissioning groups (CCGs) to support them in commissioning services for their local population is one of the key duties of NHS England. The approach NHS England must take in setting allocations is outlined in the mandate from the Department which says:</p><p><em> </em></p><p>“The Government expects the principle of ensuring equal access for equal need to be at the heart of NHS England’s approach to allocating budgets.”</p><p> </p><p>The approach is also informed by NHS England’s duty to reduce inequalities to accessing services and the outcomes of care.</p><p> </p><p>These two aims are reflected in the target formula, which produces a target allocation or ‘fair share’ for each area, based on a complex assessment of factors such as demography, morbidity, deprivation, and the unavoidable cost of providing services in different areas. The NHS England Board has agreed a pace of change policy that seeks to bring all CCGs to target funding over time.</p><p> </p><p>The formula is based on independent academic research and is overseen by an independent external group, the Advisory Committee on Resource Allocation, which provides advice to the Secretary of State for Health and Social Care and the Chief Executive of NHS England.</p><p><strong> </strong></p> answering member constituency Wimbledon answering member printed Stephen Hammond question first answered 22/07/2019 15:41:44 answering member 1585 label Biography information for Stephen Hammond
tabling member	4717 label Biography information for Ms Lisa Forbes

1139222

registered interest
date	16/07/2019
answering body	Department for Business, Energy and Industrial Strategy
answering dept id	201
answering dept short name	Business, Energy and Industrial Strategy
answering dept sort name	Business, Energy and Industrial Strategy
hansard heading	Research: Finance
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Business, Energy and Industrial Strategy, what assessment he has made of the equity of the distribution of research and development spending for areas with poor health outcomes.
tabling member constituency	Bolton West
tabling member printed	Chris Green
uin	277765
answer	answer is ministerial correction date of answer 22/07/2019 answer text <p>I refer the hon. Member to the answer I gave the hon. Member for Newcastle upon Tyne Central (Chi Onwurah MP) on 9 May 2019 to Question <a href="https://www.parliament.uk/business/publications/written-questions-answers-statements/written-question/Commons/2019-04-30/249283/" target="_blank">249283</a>. Further to that answer, on 11 July 2019 the Government announced £135 million of funding to support National Institute for Health Research (NIHR) Applied Research Collaborations (ARCs). The NIHR ARC scheme will support high-quality applied health and care research to make tangible improvements for patients, the public and to health and care services. NIHR ARCs will work with local partners and patients and the public from across the local communities they serve, and particularly with Academic Health Science Networks, to tackle local health and care priorities.</p> answering member constituency Kingswood answering member printed Chris Skidmore question first answered 22/07/2019 15:18:24 answering member 4021 label Biography information for Chris Skidmore
tabling member	4398 label Biography information for Chris Green

1139223

registered interest
date	16/07/2019
answering body	Department for Business, Energy and Industrial Strategy
answering dept id	201
answering dept short name	Business, Energy and Industrial Strategy
answering dept sort name	Business, Energy and Industrial Strategy
hansard heading	Research: Finance
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Business, Energy and Industrial Strategy, what steps he plans to take to ensure that the Government's target of increasing research and development funding to 2.4 per cent of GDP benefits the areas with the poorest health outcomes, particularly parts of the north of England.
tabling member constituency	Bolton West
tabling member printed	Chris Green
uin	277766
answer	answer is ministerial correction date of answer 22/07/2019 answer text <p>The 2.4% R&amp;D Roadmap will set overall direction for how we can achieve the 2.4% R&amp;D ambition by 2027, and 3% in the longer term, through the use of strategic public funding to leverage private R&amp;D investment.</p><p>It aims to transform R&amp;D intensity across all sectors of the economy, supporting the development of new technologies, industries, and products that bring growth, good jobs across the UK, and social improvements for all.</p><p>The 2.4% R&amp;D Roadmap will bring together Government, academia, and industry to collaboratively focus their efforts on increasing R&amp;D investment. In the area of health, this includes the Department of Health and Social Care and NHS R&amp;D activity, and work with industry in taking forward the Life Sciences Sector Deal. The 2.4% R&amp;D Roadmap will also align closely with the Industrial Strategy’s Grand Challenges. This includes the Ageing Society Grand Challenge which will create new demands for technologies, products and services for an ageing population, and the AI and Data Grand Challenge which will use data, artificial intelligence, and innovation to transform the prevention, early diagnosis, and treatment of diseases like cancer, diabetes, heart disease, and dementia by 2030.</p><p>In order to achieve the 2.4% R&amp;D target, we need to accelerate the growth and build on R&amp;D strengths across the UK. The Government has put in place a number of initiatives to support every part of the UK to identify and leverage their R&amp;D strengths, from Science and Innovation Audits to the Strength in Places Fund. The Strength in Places Fund (SIPF) is investing £237m up to 2021-22 in growing new and existing centres of excellence for research and innovation across the UK.</p><p>We are working with Local Economic Partnerships as they develop Local Industrial Strategies to identify science and innovation strengths and the action needed to unlock R&amp;D growth in places across the country.</p> answering member constituency Kingswood answering member printed Chris Skidmore question first answered 22/07/2019 15:15:15 answering member 4021 label Biography information for Chris Skidmore
tabling member	4398 label Biography information for Chris Green